We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-5.18%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$4.86B
AUM Growth
-$412M
Cap. Flow
+$88.2M
Cap. Flow %
1.81%
Top 10 Hldgs %
32.54%
Holding
208
New
15
Increased
86
Reduced
85
Closed
22

Top Buys

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$67.9M
2
LTH icon
Life Time Group Holdings
LTH
+$64.3M
3
CHGG icon
Chegg
CHGG
+$42.3M
4
ENVX icon
Enovix
ENVX
+$41.2M
5
EEFT icon
Euronet Worldwide
EEFT
+$30.6M

Top Sells

Rank Stock Value
1
ENPH icon
Enphase Energy
ENPH
+$60.1M
2
GTLS
Chart Industries
GTLS
+$52M
3
WK icon
Workiva
WK
+$40M
4
KRNT icon
Kornit Digital
KRNT
+$30.5M
5
RSKD icon
Riskified
RSKD
+$25.7M

Sector Composition

Rank Sector Weight
1 Technology 35.92%
2 Healthcare 18.43%
3 Industrials 16.38%
4 Consumer Discretionary 12.45%
5 Financials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARCT icon
176
Arcturus Therapeutics
ARCT
$200M
$2.05M 0.04%
55,405
-17,772
-24% -$724K
KZR
177
DELISTED
Kezar Life Sciences
KZR
$1.94M 0.04%
+11,626
New +$1.31M
ME
178
DELISTED
23andMe Holding Co
ME
$1.76M 0.04%
13,189
-2,132
-14% -$394K
XERS icon
179
Xeris Biopharma Holdings
XERS
$1.46B
$1.54M 0.03%
524,612
+59,563
+13% +$129K
JNCE
180
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.41M 0.03%
168,424
-5,751
-3% -$47.4K
CRBU icon
181
Caribou Biosciences
CRBU
$165M
$1.24M 0.03%
82,127
-59,824
-42% -$1.16M
MITK icon
182
Mitek Systems
MITK
$837M
$448K 0.01%
25,242
-836,882
-97% -$15M
ENPC.WS
183
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
$282K 0.01%
415,891
-8,302
-2% -$5.96K
RCEL icon
184
Avita Medical
RCEL
$235M
$260K 0.01%
21,732
+5,825
+37% +$88.8K
LFMD icon
185
LifeMD
LFMD
$174M
$209K ﹤0.01%
53,954
-108,821
-67% -$514K
KRRO icon
186
Korro Bio
KRRO
$199M
$202K ﹤0.01%
787
-74
-9% -$22.5K
AMRC icon
187
Ameresco
AMRC
$1.34B
– –
-142,844
Closed -$8.35M
AUTL
188
Autolus Therapeutics
AUTL
$551M
– –
-176,683
Closed -$1.16M
CLNE icon
189
Clean Energy Fuels
CLNE
$355M
– –
-670,093
Closed -$5.46M
ESPR
190
DELISTED
Esperion Therapeutics
ESPR
– –
-293,766
Closed -$3.54M
NGNE icon
191
Neurogene
NGNE
$729M
– –
-6,267
Closed -$906K
PRLB icon
192
Protolabs
PRLB
$2.14B
– –
-46,611
Closed -$3.1M
RSKD icon
193
Riskified
RSKD
$712M
– –
-1,127,069
Closed -$25.7M
SGMO
194
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-348,473
Closed -$3.14M
STIM icon
195
Neuronetics
STIM
$151M
– –
-880,203
Closed -$5.77M
STRA icon
196
Strategic Education
STRA
$1.84B
– –
-308,893
Closed -$21.8M
VIEW
197
DELISTED
View, Inc. Class A Common Stock
VIEW
– –
-40,730
Closed -$13.2M
BFX
198
DELISTED
BowFlex Inc.
BFX
– –
-1,595,350
Closed -$14.9M
CSII
199
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-362,330
Closed -$11.9M
TPTX
200
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-44,467
Closed -$2.95M
5 6 7
8
9

Similar funds

BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Granahan Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, Granahan Investment Management held 208 positions worth $4.86B, down 7.8% from $5.27B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management's Q4 2021 filing shows 15 new, 86 increased, 85 reduced and 22 closed positions. Its largest new stake was Stratasys: 2,436,279 shares worth $59.7M. The largest sale was Enphase Energy, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q4 2021 buy was Stratasys: 2,436,279 shares worth $59.7M.
  • Granahan Investment Management added most to Chegg in Q4 2021, an estimated $42.3M increase.
  • Granahan Investment Management's biggest Q4 2021 reduction was Enphase Energy, cutting an estimated $60.1M.
  • Granahan Investment Management fully exited Riskified in Q4 2021, selling an estimated $25.7M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $4.86B portfolio in Q4 2021.
  • Granahan Investment Management opened 15 new positions and closed 22 in Q4 2021.
  • Granahan Investment Management's portfolio value fell 7.8% quarter-over-quarter to $4.86B.

Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.